I am traveling to Panamá this Friday. Here are some interesting facts about the country’s health care system. Life expectancy is better than the U.S. Life expectancy in Panamá is 79.59 compared to 79.30 in the U.S.Mix of public and private health insurance. Panama’s healthcare architecture rests on two distinct public pillars. The Caja de Seguro…
By KRISTINA SMITH & PHIYEN NGUYEN Policymakers and advocates often promote drug price transparency to lower costs and improve equity. While transparency is an important first step toward accountability and informed public budgeting, it does not guarantee affordable prices or fair access to medicines. Transparency Has Some Benefits Drug price transparency helps show how and…
About a year ago, I was stationed in downtown D.C. on an especially chilly spring day, watching hundreds of federal employees line up outside their office buildings. In a humbling exercise, employees were waiting to test whether their entry badges still worked at the Department of Health and Human Services — or whether they’d be walked back…
Arrowhead Pharmaceuticals’ RNAi drug plozasiran, brand name Redemplo, is now the second FDA-approved therapy for familial chylomicronemia syndrome, an inherited lipid disorder. Beyond its claims of safety and dosing advantages, Arrowhead set a dramatically lower price for its first commercial product, which will compete against an Ionis Pharmaceuticals drug. The post With FDA Approval for…
Modern trial designs, digital solutions and a deeper understanding of patient realities are helping to open research to more people, including women and others who have historically been underrepresented. The post Better Science, Better Medicine: How Clinical Research Advances Women’s Health appeared first on MedCity News.
I had a great conversation and demo with Katie Logan and Christine Smith from Gozio a while back. Finally got it up on THCB. Gozio provides two types of patient navigation for health systems. One as a digital front door helping patients navigate to doctors, services and tools like virtual care and appointments from the…
In this episode, we’re joined by Kathryn Schubert, president and CEO of the Society for Women’s Health Research. Schubert discusses the trends in women’s health that defined 2024 and what we can expect in the coming year. The post MedCity FemFwd: What the Future Holds for Women’s Health in 2025 appeared first on MedCity News.
Para apoyar la decisión del secretario Robert F. Kennedy Jr. de cambiar la política nacional sobre las vacunas contra covid-19, el Departamento de Salud y Servicios Humanos (HHS) envió a los legisladores un documento que cita estudios científicos inéditos o controversiales, y tergiversa otros. Un experto en salud calificó el documento de “desinformación médica deliberada”…
Joint Commission certification and CHAI’s governance playbooks are tightly aligned on the need for responsible and transparent AI
Rocket Pharmaceuticals received FDA approval for Kresladi, a gene therapy developed to treat leukocyte-adhesion deficiency type 1, an inherited immunodeficiency that can become fatal to infants and young children. Kresladi is the first gene therapy for this ultra-rare disease and the first commercial product for Rocket. The post FDA Approval Makes Rocket Pharma Gene Therapy…